These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 22919876)

  • 1. Clinical significance of haemostatic tests in chronic liver disease.
    Saray A; Mesihovic R; Vanis N; Gornjakovic S; Prohic D
    Med Arch; 2012; 66(4):231-5. PubMed ID: 22919876
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of Both Protein C and Antithrombin III as Predictors of Stage of Liver Disease in Chronic Viral Hepatitis B or C Infected Patients.
    Abo-Elenein AM; Mabrouk MM; Abou-Saif S; Saeed OM; Khodeir S; Elkadeem M; Elashry H; Haydara T; Zaghloul MS; Seleem WM; Elshweikh SA; Abd-Elsalam S
    Endocr Metab Immune Disord Drug Targets; 2020; 20(1):112-117. PubMed ID: 31142255
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Importance of anticoagulant proteins in chronic liver diseases.
    Gürsoy S; Başkol M; Torun E; Yurci A; Soyuer I; Eser B; Güven K; Ozbakir O; Yücesoy M
    Turk J Gastroenterol; 2005 Sep; 16(3):129-33. PubMed ID: 16245221
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protein C and D-dimer are related to portal vein thrombosis in patients with liver cirrhosis.
    Zhang D; Hao J; Yang N
    J Gastroenterol Hepatol; 2010 Jan; 25(1):116-21. PubMed ID: 19686413
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical significance of fibrotic, haemostatic and endotoxic changes in patients with liver cirrhosis.
    Li CJ; Yang ZH; Lu FG; Shi XL; Liu DL
    Acta Gastroenterol Belg; 2018; 81(3):404-409. PubMed ID: 30350529
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The coagulopathy of liver disease: does vitamin K help?
    Saja MF; Abdo AA; Sanai FM; Shaikh SA; Gader AG
    Blood Coagul Fibrinolysis; 2013 Jan; 24(1):10-7. PubMed ID: 23080365
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protein C Deficiency in Chronic Hepatitis C: Correlation With Histological Extent of Liver Fibrosis.
    Saray A; Mesihovic R; Vanis N; Amila M
    Clin Appl Thromb Hemost; 2017 Jan; 23(1):72-77. PubMed ID: 26008227
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Disseminated intravascular coagulation in liver cirrhosis: fact or fiction?
    Ben-Ari Z; Osman E; Hutton RA; Burroughs AK
    Am J Gastroenterol; 1999 Oct; 94(10):2977-82. PubMed ID: 10520855
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hemostasis activation in patients with liver cirrhosis.
    Vukovich T; Teufelsbauer H; Fritzer M; Kreuzer S; Knoflach P
    Thromb Res; 1995 Feb; 77(3):271-8. PubMed ID: 7740519
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The relationship between hemostatic changes in liver cirrhosis patients with different degrees of liver lesions in reference to Child-Pugh scores].
    Cong YL; Wei YX; Zhang LW; Yin ZJ; Bai J
    Zhonghua Gan Zang Bing Za Zhi; 2005 Jan; 13(1):31-4. PubMed ID: 15670488
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Haemostatic abnormalities in liver disease: could some haemostatic tests be useful as liver function tests?
    Al Ghumlas AK; Abdel Gader AG; Al Faleh FZ
    Blood Coagul Fibrinolysis; 2005 Jul; 16(5):329-35. PubMed ID: 15970716
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circadian rhythms of fibrinogen and antithrombin III in liver cirrhosis.
    Pasqualetti P; Casale R
    Riv Eur Sci Med Farmacol; 1995; 17(4):125-9. PubMed ID: 8545565
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hemostatic changes in patients with liver cirrhosis.
    Ho CH; Hou MC; Lin HC; Lee FY; Wu JC; Lee SD
    Zhonghua Yi Xue Za Zhi (Taipei); 1999 Jun; 62(6):376-82. PubMed ID: 10389296
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of coagulation parameters in the early period after kidney transplantation.
    Pawlicki J; Cierpka L; Król R; Ziaja J
    Transplant Proc; 2007 Nov; 39(9):2754-5. PubMed ID: 18021978
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Changing characteristic of blood coagulation factors and their correlation with blood coagulation status in different hepatic diseases].
    Chen J; Duan ZP; Bai L; Zhao J; Ding M; Tong XY; Cong YL
    Zhonghua Gan Zang Bing Za Zhi; 2012 Mar; 20(3):206-10. PubMed ID: 22475141
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of sustained virus elimination on natural anticoagulant activity in patients with chronic viral hepatitis C.
    Saray A; Mesihović R; Vukobrat-Bijedić Z; Gornjaković S; Vanis N; Mehmedović A; Papović V; Glavaš S
    Bosn J Basic Med Sci; 2013 May; 13(2):84-8. PubMed ID: 23725503
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activated-protein-C resistance in cancer patients.
    Green D; Maliekel K; Sushko E; Akhtar R; Soff GA
    Haemostasis; 1997; 27(3):112-8. PubMed ID: 9306127
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The influence of antithrombin III (AT III) substitution to supranormal activities on systemic procoagulant turnover in patients with end-stage chronic liver disease.
    Scherer R; Kabatnik M; Erhard J; Peters J
    Intensive Care Med; 1997 Nov; 23(11):1150-8. PubMed ID: 9434921
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Biochemical markers of fibrosis in chronic hepatitis and liver cirrhosis of viral origin].
    Kozłowska J; Łoch T; Jabłońska J; Cianciara J
    Przegl Epidemiol; 2001; 55(4):451-8. PubMed ID: 11921731
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The value of coagulation factors in severity categorization of hepatitis B-related liver cirrhosis].
    Li Q; Wang BE; Cong YL; Jia JD; Yin ZJ; Qian LX; Ma H
    Zhonghua Nei Ke Za Zhi; 2005 Mar; 44(3):188-90. PubMed ID: 15840257
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.